These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16835371)

  • 1. Interaction of amphetamines and related compounds at the vesicular monoamine transporter.
    Partilla JS; Dempsey AG; Nagpal AS; Blough BE; Baumann MH; Rothman RB
    J Pharmacol Exp Ther; 2006 Oct; 319(1):237-46. PubMed ID: 16835371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
    Ding D; Nickell JR; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2613-6. PubMed ID: 25991431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
    Volz TJ; Farnsworth SJ; King JL; Riddle EL; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2007 Nov; 323(2):738-45. PubMed ID: 17693585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells.
    Maurel A; Spreux-Varoquaux O; Amenta F; Tayebati SK; Tomassoni D; Seguelas MH; Parini A; Pizzinat N
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1592-8. PubMed ID: 17244889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1150-3. PubMed ID: 11504813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.
    Freyberg Z; Sonders MS; Aguilar JI; Hiranita T; Karam CS; Flores J; Pizzo AB; Zhang Y; Farino ZJ; Chen A; Martin CA; Kopajtic TA; Fei H; Hu G; Lin YY; Mosharov EV; McCabe BD; Freyberg R; Wimalasena K; Hsin LW; Sames D; Krantz DE; Katz JL; Sulzer D; Javitch JA
    Nat Commun; 2016 Feb; 7():10652. PubMed ID: 26879809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.
    Naudon L; Raisman-Vozari R; Edwards RH; Leroux-Nicollet I; Peter D; Liu Y; Costentin J
    Eur J Neurosci; 1996 Apr; 8(4):842-6. PubMed ID: 9081637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the mechanism of action of amphetamines.
    Fleckenstein AE; Volz TJ; Riddle EL; Gibb JW; Hanson GR
    Annu Rev Pharmacol Toxicol; 2007; 47():681-98. PubMed ID: 17209801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion increases striatal vesicular monoamine transport.
    Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2.
    Noskova V; Bottalico B; Olsson H; Ehinger A; Pilka R; Casslén B; Hansson SR
    Mol Hum Reprod; 2006 Aug; 12(8):483-9. PubMed ID: 16567367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.
    Sagné C; Isambert MF; Vandekerckhove J; Henry JP; Gasnier B
    Biochemistry; 1997 Mar; 36(11):3345-52. PubMed ID: 9116013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
    Volz TJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
    Truong JG; Wilkins DG; Baudys J; Crouch DJ; Johnson-Davis KL; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1087-92. PubMed ID: 15901804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC; Vander Borght T; Sherman PS; Frey KA; Kilbourn MR
    J Med Chem; 1996 Jan; 39(1):191-6. PubMed ID: 8568807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe.
    Gopalakrishnan A; Sievert M; Ruoho AE
    Mol Pharmacol; 2007 Dec; 72(6):1567-75. PubMed ID: 17766642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.
    Yaffe D; Vergara-Jaque A; Forrest LR; Schuldiner S
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7390-E7398. PubMed ID: 27821772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration.
    Tong J; Wilson AA; Boileau I; Houle S; Kish SJ
    Synapse; 2008 Nov; 62(11):873-6. PubMed ID: 18720517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.